You are here: Industry Insights > Strides

News List

Strides gets USFDA nod for Oxybutynin Chloride Tablets expresspharma
December 21, 2020
Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global, Singapore, has received approval for Oxybutynin Chloride Tablets USP, 5 mg from the United States Food & Drug Administration (USFDA).
Strides receives USFDA approval for Ethacrynic Acid Tablets expresspharma
October 22, 2020
Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global, Singapore, has received approval for Ethacrynic Acid Tablets USP, 25 mg from the United States Food & Drug Administration (USFDA).
Strides gets USFDA approval for butalbital, acetaminophen and caffeine tablets expresspharma
September 23, 2020
They are indicated for the relief of the symptom complex of tension or muscle contraction headache.
Strides to invest Rs 1350 mn in 24 months in SteriScience, sterile injectables arm expresspharma
September 15, 2020
Strides Pharma Science announced that it is investing in SteriScience Pharma to make it the company’s dedicated arm for global sterile injectables business.
Strides gets USFDA approval for Ursodiol tablets expresspharma
August 24, 2020
Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global, Singapore, has received approval for Ursodiol tablets USP, 250 mg and 500 mg from the United States Food & Drug Administration (USFDA).
UK MHRA inspection of Strides facility at Puducherry concludes successfully expresspharma
August 20, 2020
Strides Pharma Science announced the successful completion of the inspection carried out by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA) at its Puducherry facility between 15-18 October 2019.
Strides receives USFDA approval for Triamcinolone Acetonide Ointment expresspharma
June 03, 2020
Product approval from flagship facility in Bangalore, to be marketed by Strides Pharma in the US.
Strides receives USFDA approval for flucytosine capsules expresspharma
April 21, 2020
Product approval from flagship facility in Bengaluru; to be marketed by Strides Pharma Inc in the US market.
Strides receives US FDA approval for Tetracycline Hydrochloride Capsules expresspharma
March 05, 2020
The product is a generic version of Achromycin V Capsules, 250 mg and 500 mg, of Avet Pharmaceuticals Inc (previously Heritage Pharmaceuticals.
Strides completes US FDA inspection at its Alathur facility expresspharma
August 15, 2019
Strides Pharma Science recently announced that its formulation facility at Alathur, Chennai, India underwent a US FDA inspection starting August 05, 2019 and the inspection concluded with “Zero 483 observations”.

Previous page 1 2 3 4 Next page